Viriom Inc (San Diego, CA) signed a licensing agreement with P.T. Lloyd Pharma Indonesia as a part of its global strategy to help combat HIV drug resistance problem in developing markets by using innovative, safe and efficacious treatment and prevention options with Elpida® as well as other drugs from Viriom HIV and HBV portfolio.

SAN DIEGO, June 3, 2019 -- Iain Dukes, CEO of Viriom Inc (San Diego, CA), presented Viriom's strategy on high growth developing markets, which includes obtaining a market authorization in China, at the 11th ChinaBio Annual International Partnering Conference in Shanghai.

Viriom Inc. is pleased to announce the appointment of Iain Dukes, M.A., D.Phil., as its new CEO. Dr. Dukes brings to Viriom over 20 years of extensive experience in drug discovery, pharmaceutical research and business development, as well as in leadership and consulting for numerous biotech and venture capital organizations.